Compare Vertiv Holdings Co (VRT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertiv Holdings Co vs Zimmer Biomet Holdings Inc — how do they compare? Vertiv Holdings Co trades at $258.88 (market cap $101.21B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Vertiv Holdings Co is far larger — about 5.6× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.01%). Which is the better fit depends on your goals.
| VRT | ZBH | |
|---|---|---|
Market Cap | $101.21B | $18.05B |
Sector | Technology | Health |
52-Week High | $376.23 | $104.26 |
52-Week Low | $134.84 | $79.58 |
Enterprise Value | $101.44B | $25.11B |
Dividend Yield | 0.1% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertiv Holdings Co. (VRT) trades at $290.83, up 3.67% today, reflecting strong momentum. The stock exhibits a bullish technical trend, supported by robust fundamentals including consistent earnings beats and projected revenue growth from $10.23B in 2025 to $11.5B in 2026. Recent news highlights its strategic acquisition of UtilityInnovation Group for up to $2.6B, positioning it at the forefront of AI-driven data center infrastructure demand.
Outlook remains positive given Wall Street's strong buy consensus (95% buy ratings) and a $355.17 price target, implying 22% upside. Key risks include execution of acquisitions, high valuation multiples, and sensitivity to AI capex cycles. The stock presents a growth opportunity tied to data center expansion, but investors should weigh premium valuations against earnings delivery.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
